Business Description
Vaidya Sane Ayurved Laboratories Ltd
ISIN : INE0JR301013
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 11.54 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.27 | |||||
Interest Coverage | 8.76 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 7.85 | |||||
Beneish M-Score | -1.63 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.5 | |||||
3-Year EBITDA Growth Rate | 17.5 | |||||
3-Year EPS without NRI Growth Rate | -1.2 | |||||
3-Year Book Growth Rate | 78.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.57 | |||||
9-Day RSI | 36.23 | |||||
14-Day RSI | 41.16 | |||||
6-1 Month Momentum % | -10.13 | |||||
12-1 Month Momentum % | -36.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.4 | |||||
Quick Ratio | 2.11 | |||||
Cash Ratio | 1.39 | |||||
Days Inventory | 51.72 | |||||
Days Sales Outstanding | 24.32 | |||||
Days Payable | 101.57 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -11.06 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 74.12 | |||||
Operating Margin % | 2.19 | |||||
Net Margin % | 1.99 | |||||
FCF Margin % | -15.66 | |||||
ROE % | 3.94 | |||||
ROA % | 3.05 | |||||
ROIC % | 4.04 | |||||
ROC (Joel Greenblatt) % | 13.62 | |||||
ROCE % | 6 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 88.41 | |||||
PE Ratio without NRI | 104.44 | |||||
PEG Ratio | 3.84 | |||||
PS Ratio | 1.77 | |||||
PB Ratio | 2.62 | |||||
Price-to-Tangible-Book | 3 | |||||
EV-to-EBIT | 41.2 | |||||
EV-to-EBITDA | 20.5 | |||||
EV-to-Revenue | 1.29 | |||||
EV-to-FCF | -8.25 | |||||
Price-to-Peter-Lynch-Fair-Value | 4.26 | |||||
Price-to-Graham-Number | 3.73 | |||||
Price-to-Net-Current-Asset-Value | 8.03 | |||||
Price-to-Net-Cash | 35.87 | |||||
Earnings Yield (Greenblatt) % | 2.43 | |||||
FCF Yield % | -10.66 | |||||
Forward Rate of Return (Yacktman) % | 13.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Vaidya Sane Ayurved Laboratories Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 993.313 | ||
EPS (TTM) (₹) | 1.57 | ||
Beta | 0 | ||
Volatility % | 39.31 | ||
14-Day RSI | 41.16 | ||
14-Day ATR (₹) | 6.1955 | ||
20-Day SMA (₹) | 147.33 | ||
12-1 Month Momentum % | -36.86 | ||
52-Week Range (₹) | 107 - 251 | ||
Shares Outstanding (Mil) | 10.51 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vaidya Sane Ayurved Laboratories Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vaidya Sane Ayurved Laboratories Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Vaidya Sane Ayurved Laboratories Ltd Frequently Asked Questions
What is Vaidya Sane Ayurved Laboratories Ltd(NSE:MADHAVBAUG)'s stock price today?
When is next earnings date of Vaidya Sane Ayurved Laboratories Ltd(NSE:MADHAVBAUG)?
Does Vaidya Sane Ayurved Laboratories Ltd(NSE:MADHAVBAUG) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |